MSC2530818
Pwodwi detay
Tags pwodwi
Gwosè pake | Disponibilite | Pri (USD) |
100 mg | Nan Stock | 400 |
Plis gwosè | Jwenn Quotes | Jwenn Quotes |
Non Chimik:
[(2S)-2-(4-Chlorophenyl)pyrrolidin-1-yl]-(3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)methanone
Kòd SMILES:
O=C(N1[C@H](C2=CC=C(Cl)C=C2)CCC1)C3=CN=C(NN=C4C)C4=C3
Kòd InChi:
InChI=1S/C18H17ClN4O/c1-11-15-9-13(10-20-17(15)22-21-11)18(24)23-8-2-3-16(23)12-4- 6-14(19)7-5-12/h4-7,9-10,16H,2-3,8H2,1H3,(H,20,21,22)/t16-/m0/s1
InChi kle:
ODRITQGYYWHQGM-INIZCTEOSA-N
Mot:
MSC2530818, MSC-2530818, MSC 2530818, 1883423-59-3
Solibilite:Soluble nan DMSO
Depo:0 - 4 ° C pou kout tèm (jou a semèn), oswa -20 ° C pou tèm long (mwa).
Deskripsyon:
MSC2530818 se yon Inibitè CDK8 ki pisan, selektif, ak oral byodisponib ak CDK8 IC50 = 2.6 nM; Prediksyon PK imen: Cl ~ 0.14 L/H/Kg; t1/2 ~ 2.4h; F > 75%. MSC2530818 montre ekselan selektivite kinaz, puisans byochimik ak selilè, estabilite mikwosomal, epi li se biodisponib oral. MSC2530818 demontre pisans apwopriye ak selektivite pou pwogrese nan etid preklinik sou efikasite ak sekirite nan vivo.
Sib: CDK